(DESIGNS FOR) NON-CONTACT LASER CAPTURE MICRODISSECTION Read more about (DESIGNS FOR) NON-CONTACT LASER CAPTURE MICRODISSECTION US Application 60/111,662Filed on 1998-12-10
COMPOSITIONS AND METHODS FOR IDENTIFYING AND TESTING TYROSINE KINASE SUBSTRATES AND THEIR AGONISTS AND ANTAGONISTS (As Filed) Read more about COMPOSITIONS AND METHODS FOR IDENTIFYING AND TESTING TYROSINE KINASE SUBSTRATES AND THEIR AGONISTS AND ANTAGONISTS (As Filed) US Application 60/068,690Filed on 1997-12-23
HEXADECASACCHARIDE-PROTEIN CONJUGATE VACCINE FOR SHIGELLA DYSENTERIAE TYPE 1 Read more about HEXADECASACCHARIDE-PROTEIN CONJUGATE VACCINE FOR SHIGELLA DYSENTERIAE TYPE 1 US Application 60/052,869Filed on 1997-07-17
METHOD FOR DETECTING CANCER PREDISPOSING MUTATIONS Read more about METHOD FOR DETECTING CANCER PREDISPOSING MUTATIONS US Application 60/040,157Filed on 1997-03-07
USE OF ANTISENSE OSTEOPONTIN (OPN) OLIGONUCLEOTIDES FOR PREVENTION OF CORONARY RESTENOSIS FOLLOWING ANGIOPLASTY Read more about USE OF ANTISENSE OSTEOPONTIN (OPN) OLIGONUCLEOTIDES FOR PREVENTION OF CORONARY RESTENOSIS FOLLOWING ANGIOPLASTY US Application 60/054,967Filed on 1997-08-07
ACTIVITY-DEPENDENT NEUROTROPHIC FACTOR (ADNF) III Read more about ACTIVITY-DEPENDENT NEUROTROPHIC FACTOR (ADNF) III US Application 60/037,404Filed on 1997-02-07
NOVEL MOUSE MODEL FOR NON-INSULIN DEPENDENT (TYPE II) DIABETES MELLITUS Read more about NOVEL MOUSE MODEL FOR NON-INSULIN DEPENDENT (TYPE II) DIABETES MELLITUS US Application 60/019,412Filed on 1996-06-07
METHODS AND COMPOSITIONS FOR p300/CBP ASSOCIATED TRANSCRIPTIONAL CO-FACTOR P/CAF Read more about METHODS AND COMPOSITIONS FOR p300/CBP ASSOCIATED TRANSCRIPTIONAL CO-FACTOR P/CAF US Application 60/022,273Filed on 1996-07-23
NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF Read more about NUCLEOTIDE AND AMINO ACID SEQUENCES OF THE BRX GENE AND GENE PRODUCT, AND USES THEREOF US Application 60/059,621Filed on 1997-09-23
OLIGO- OR POLY a (1-2)-D-GLUCOSE-BASED VACCINE FOR PREVENTION AND FOR TREATMENT OF TUBERCULOSIS Read more about OLIGO- OR POLY a (1-2)-D-GLUCOSE-BASED VACCINE FOR PREVENTION AND FOR TREATMENT OF TUBERCULOSIS US Application 60/019,077Filed on 1996-06-03